All In Biotech

Free tool

FAERS Monitor: Zoledronic Acid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203231 or its brand name (Zoledronic Acid, Zoledronic Acid). Reports on generic versions are filed under their own applications.

Reports

27,217

Serious

25,233

93% of reports

Hospitalization

8,992

Death reported

3,128

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • osteonecrosis of jaw2,541
  • fatigue1,931
  • nausea1,778
  • diarrhoea1,776
  • pyrexia1,668
  • off label use1,602
  • pain1,456
  • arthralgia1,433
  • neutropenia1,410
  • vomiting1,409
  • asthenia1,338
  • malignant neoplasm progression1,202
  • headache1,198
  • decreased appetite1,068
  • dyspnoea1,064

Reports by year received

View as table
YearReports
200440
200592
2006108
2007227
2008419
2009563
2010324
2011874
2012362
2013385
2014431
2015700
2016931
20171,135
20181,718
20192,096
20202,222
20212,202
20222,342
20232,535
20242,713
20252,908
20261,889

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,026,942 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
osteonecrosis of jawSignal2,54188.384.9196,992
malignant neoplasm progressionSignal1,2029.28.78,676
neutropeniaSignal1,4108.17.78,716
pyrexiaSignal1,6683.73.63,383
decreased appetiteSignal1,0683.63.41,981
astheniaSignal1,3382.82.61,517
arthralgiaSignal1,4332.72.51,519
vomitingSignal1,4092.32.21,078
diarrhoeaSignal1,7762.12.01,093
fatigue1,9311.91.8879
pain1,4561.81.7566
nausea1,7781.71.7577
headache1,1981.51.4190
dyspnoea1,0641.51.4154
off label use1,6021.41.3202

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.